Supplement for pregnant women with malaria could improve birth outcomes

March 07, 2018

Pregnant women infected with malaria have lower levels of an essential amino acid called L-arginine, which may help to explain why these women are more likely to experience complications such as stillbirths and low birth weight infants. Malaria infection in pregnancy (MIP) is a leading cause of maternal-child morbidity and mortality worldwide, and as such reducing adverse birth outcomes is a global health priority - yet few safe and effective interventions exist. Here, Chloe McDonald and colleagues found that low levels of L-arginine in a group of 384 pregnant women in Malawi were associated with worse pregnancy outcomes. Working in pregnant mice, the researchers observed that those infected with malaria benefited from L-arginine supplementation, increasing viability and birth weights among the pups delivered. They found the amino acid plays a key role in the synthesis of nitric oxide, which guides the development of blood vessels in the placenta. McDonald et al. used imaging of the pregnant mice with malaria to confirm how L-arginine supplementation reduces inflammation and prompts vascular development in the placenta. Each year, about 125 million women become pregnant in regions where malaria is endemic and where diets are poor in L-arginine. In a related Focus, James Beeson and colleagues discuss the "potential simplicity, affordability and practicality" of amino acid supplementation for these women. The study authors say that novel interventions aimed at promoting placental function may improve birth outcomes not only for MIP, but also for other causes of adverse pregnancy outcomes associated with placental insufficiency.
-end-


American Association for the Advancement of Science

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.